Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology News Journal.
Methode Electronics to Release Fourth Quarter and Full Year Fiscal 2025 Results on Wednesday, July 9, 2025
GlobeNewswire, Inc.
·
July 3, 2025
CHICAGO, July 03, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting system and power distribution applications, announced it will release its...
Investor Alert: Johnson Fistel Investigates Methode Electronics, Integral Ad Science, Manhattan Associates, and Crocs on Behalf of Shareholders
GlobeNewswire, Inc.
·
July 3, 2025
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Methode Electronics, Inc. (NYSE: MEI),...
Diversified Botanics Welcomes Dr. Robert R. Redfield Jr. to Board of Directors Mission to Combat Emerging Opioid Crisis
EIN Presswire
·
July 9, 2025
BALTIMORE, MD, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Diversified Botanics, a pioneering science-based firm at the forefront of botanical health and wellness, is thrilled to announce that Dr. Robert R. Redfield Jr., renowned...
Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines
GlobeNewswire, Inc.
·
July 3, 2025
BOSTON, July 03, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the publication of groundbreaking new...
Excelitas Publishes 2024 Sustainability Report
GlobeNewswire, Inc.
·
July 9, 2025
PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Excelitas®, a leading provider of advanced, life-enriching technologies that make a difference, serving global market leaders in the life sciences, advanced industrial, next-generation semiconductor...
Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application
GlobeNewswire, Inc.
·
July 9, 2025
KANSAS CITY, Kan., July 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of...
Azerion announces definitive agreement with DoubleDown Interactive for the sale of Whow Games Company sharpens focus on digital advertising, cloud services and AI
GlobeNewswire, Inc.
·
July 9, 2025
Amsterdam, 9 July 2025 – Azerion, a leading European digital advertising platform, today announces the sale of its subsidiary Whow Games, the lion’s share of its Premium Games segment, to DoubleDown Interactive, part of South Korea-based...
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
GlobeNewswire, Inc.
·
July 9, 2025
HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for...
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
GlobeNewswire, Inc.
·
July 9, 2025
– John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of Successor – – Dr. Houston to Remain Chairperson of Arvinas Board of Directors – – Arvinas Board of Directors to Lead Search for...
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
GlobeNewswire, Inc.
·
July 9, 2025
NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits WATERTOWN, Mass., July 09, 2025 (GLOBE...
Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
·
July 3, 2025
Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived...
Aesthetic Medical Devices Market Projected to Hit USD 43.93Billion by 2032, Exhibiting a CAGR of 12.5% To 2025-2032
EIN Presswire
·
July 3, 2025
Aesthetic Medical Devices Market was USD 17.12 billion to reach USD 43.93 billion by 2032 at 12.5% CAGR, driven by non-invasive procedures, WILMINGTON, DE, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- Stellar Market Research examines the...
Amneal to Report Second Quarter 2025 Results on August 5, 2025
GlobeNewswire, Inc.
·
July 9, 2025
BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial...
Crown Castle Announces Second Quarter 2025 Earnings Conference Call Details
GlobeNewswire, Inc.
·
July 9, 2025
HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to release its second quarter 2025 results on Wednesday, July 23, 2025, after the market closes. In conjunction with the release, Crown Castle has...
Apex Group appoints new Chief AI and Data Science Officer to lead global AI strategy
EIN Presswire
·
July 3, 2025
LONDON, UNITED KINGDOM, July 3, 2025 /EINPresswire.com/ -- Apex Group Ltd. (“Apex Group” or “the Group”), the leading global financial services provider, announces the appointment of Helen Wang as Chief AI and Data Science Officer, based in Abu...
BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology (ESMO)…
GlobeNewswire, Inc.
·
July 3, 2025
Adverse events were generally low-grade, transient, and readily manageable Achieved preliminary evidence of prolonged tumor control and tumor reductions in heavily pretreated adenocarcinoma patients Dose escalation now continuing at 1.2 mg weekly...
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
GlobeNewswire, Inc.
·
July 3, 2025
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering...
Hohem Unveils Best Gimbal Deals of 2025 Mid-Year Mega Sale— Save Up to 50% on Flagship Models
GlobeNewswire, Inc.
·
July 9, 2025
Shenzhen, China, July 09, 2025 (GLOBE NEWSWIRE) -- As the 2025 Mid-Year Mega Sale kicks off, Hohem Tech, a global leader in gimbal innovation, is offering its best gimbal sales of the year. From July 7 to July 20 (PT),customers can enjoy up to 50%...
Covasant Technologies Announces Strategic Merger with Texas-based konaAI, and California-based DCube Data Sciences Corp to Drive Accelerated Agentic AI Adoption in Enterprise Risk Management
GlobeNewswire, Inc.
·
July 9, 2025
PLANO, Texas, July 09, 2025 (GLOBE NEWSWIRE) -- Three specialized technology firms have merged under a team of proven industry veterans to create Covasant Technologies, a new powerhouse focused on solving complex risk, compliance, and...
Weston Reserve by Toll Brothers is Now Open in Apex, North Carolina
GlobeNewswire, Inc.
·
July 9, 2025
APEX, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, has announced the opening of Weston Reserve, a new community of single-family homes in Apex, North Carolina. This exclusive...